Contineum Therapeutics CTNM
NASDAQ CTNM
$8.35 -0.11 (-1.30%)
At close: Oct 21, 2026 · 4:00 PM EDT

Contineum Therapeutics (CTNM) Interest Coverage Ratio (2023)

Updated

Contineum Therapeutics' Interest Coverage Ratio came in at 77.29 for FY2023.

Analysis

Contineum Therapeutics (CTNM) Interest Coverage Ratio (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Contineum Therapeutics 313.04 Mn -615.14 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 335.66
Mar 31, 2023 -55.60
API Access

Contineum Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=CTNM&period=max&api_key=YOUR_API_KEY